Can hypertrophic cardiomyopathy be inherited by the next generation?

Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disorder inherited in an autosomal dominant pattern. Affected family members can pass the disease-causing gene to their offspring. Some offspring carry the mutant gene but remain asymptomatic throughout life, while others develop symptoms during adolescence or middle age. Individuals with a family history of heart disease—or young people experiencing palpitations and chest tightness—should seek timely medical evaluation and screening.

The hallmark pathological feature of HCM is asymmetric myocardial hypertrophy, which impairs ventricular diastolic function and alters hemodynamics. Clinical manifestations may include palpitations, exertional dyspnea, and reduced exercise tolerance. In early-stage disease, pharmacotherapy—including agents that slow heart rate and improve myocardial diastolic function—can help stabilize cardiac rhythm and slow disease progression.

In patients with advanced disease and severe myocardial hypertrophy, medical therapy alone may fail to control disease progression. Clinically, interventions such as septal alcohol ablation or surgical myectomy may be employed to alleviate left ventricular outflow tract obstruction, thereby improving cardiac blood flow and reducing the risk of life-threatening complications—including malignant arrhythmias and sudden cardiac death.

Adopting a calm, low-stress lifestyle—avoiding intense competitive sports and excessive physical exertion—along with balanced nutrition to support myocardial health, emotional stability, and regular cardiac monitoring, are essential for maintaining long-term cardiovascular well-being.